Filing Details
- Accession Number:
- 0001104659-25-047938
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-13 18:36:36
- Reporting Period:
- 2025-05-12
- Filing Date:
- 2025-05-13
- Accepted Time:
- 2025-05-13 18:36:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1875558 | Nuvectis Pharma Inc. | NVCT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1806384 | Charles Marlio Mosseri | 27 Ripplevale Grove London N1 1HS | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-05-12 | 21,167 | $8.11 | 2,942,761 | No | 4 | P | Indirect | By Emerald Hill Ventures SARL SPF. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Emerald Hill Ventures SARL SPF. |
Footnotes
- Reflects the weighted average purchase price. The range of prices for the shares purchased was $8.11 to $8.12. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
- Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL.
Billionaire Hedge Funds
